CRC has an immunosuppressive TME which prevents the development of a highly effective response to ICB therapies. There's Therefore an urgent need to determine the methods reprogram this suppressive TME in order to greatly enhance immunotherapy efficacy. In The present research, we made use of CRISPR KO screens to find https://tommyc295fym2.ageeksblog.com/profile